Fcγ receptors as regulators of immune responses
The DOI matches its Crossref record; 138 of the 139 references it cites were found in a registry or an index.
Abstract
In addition to their role in binding antigen, antibodies can regulate immune responses through interacting with Fc receptors (FcRs). In recent years, significant progress has been made in understanding the mechanisms that regulate the activity of IgG antibodies in vivo. In this Review, we discuss recent studies addressing the multifaceted roles of FcRs for IgG (FcgammaRs) in the immune system and how this knowledge could be translated into novel therapeutic strategies to treat human autoimmune, infectious or malignant diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FcγR activation induces macrophage phagocytosis.44”
From Intestinal B cells license metabolic T-cell activation in NASH microbiota/antigen-independently and contribute to fibrosis by IgA-FcR signalling (2023) · cites this paper as [44]
Citations
Cites
Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., & Watier, H. (2002) · Blood · doi:10.1182/blood.v99.3.754 · Cited by 1,900
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Self-citationShields, R. L., Lai, J., Keck, R., O'Connell, L. Y., Hong, K., Meng, Y. G., Weikert, S. H. A., & Presta, L. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202069200 · Cited by 1,835
Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · cited 1×
“Evidence that this sugar residue is involved in immune regulatory processes was obtained by studying the mechanism of the anti-inflammatory activity of IVIG therap”
BackgroundSelf-citationDifferential Antigen Processing by Dendritic Cell Subsets in Vivo
Dudziak, D., Kamphorst, A. O., Heidkamp, G. F., Buchholz, V. R., Trumpfheller, C., Yamazaki, S., Cheong, C., Liu, K., Lee, H.-W., Park, C. G., et al. (2007) · Science · doi:10.1126/science.1136080 · Cited by 1,455
Deisenhofer, J. (1981) · PubMed · Cited by 1,422
Shinkawa, T., Nakamura, K., Yamane, N., Shoji-Hosaka, E., Kanda, Y., Sakurada, M., Uchida, K., Anazawa, H., Satoh, M., Yamasaki, M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210665200 · Cited by 1,413
Deisenhofer, J. (1981) · Biochemistry · doi:10.1021/bi00512a001 · Cited by 1,333
The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins
Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,307 · cited 1×
“This sugar side chain consists of a conserved biantennary heptasaccharide core structure containing mannose and N-acetylglucosamine (GlcNac) with varying additions of terminal and branching residues such as fucose, GlcNac, galactose and sialic aci”
BackgroundWeng, W.-K., & Levy, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.013 · Cited by 1,300 · cited 1×
“Several studies of lymphoma patients who had received Rituximab, a B-cell depleting chimeric IgG1 antibody that is specific for CD20, revealed that those patients with activating FcγR alleles that had a higher binding affinity for the Fc fragment of the therapeutic antibody displayed significantly improved clinical re…”
Background
Cited by
Items 701–800 of 1,008
Avidity confers FcγR binding and immune effector function to aglycosylated immunoglobulin G1
Nesspor, T. C., Raju, T. S., Chin, C. ‐., Vafa, O., & Brezski, R. J. (2012) · Journal of Molecular Recognition · doi:10.1002/jmr.2155 · Cited by 52
“…plays a functional role, such as T-cell activation by MHC complexes, integrin adhesiveness, and high-affinity binding of antibody immune complexes to FcgRs that only have low affinity for monomeric antibodies (Carman and Springer 2003; Nimmerjahn and Ravetch 2008; Schamel et al., 2006).”
BackgroundD’Aloia, M. M., Caratelli, S., Palumbo, C., Battella, S., Arriga, R., Lauro, D., Palmieri, G., Sconocchia, G., & Alimandi, M. (2015) · Cytotherapy · doi:10.1016/j.jcyt.2015.10.014 · Cited by 57
Involvement of B cells in non‐infectious uveitis
Smith, J. R., Stempel, A. J., Bharadwaj, A. S., & Appukuttan, B. (2016) · Clinical & Translational Immunology · doi:10.1038/cti.2016.2 · Cited by 55
Enhancement of Immune Effector Functions by Modulating IgG’s Intrinsic Affinity for Target Antigen
Mazor, Y., Yang, C., Borrok, M. J., Ayriss, J. E., Aherne, K., Wu, H., & Dall’Acqua, W. F. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157788 · Cited by 54
Leyland, R., Watkins, A., Mulgrew, K. A., Holoweckyj, N., Bamber, L., Tigue, N. J., Offer, E., Andrews, J., Yan, L., Mullins, S., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2000 · Cited by 52
IκBζ is essential for natural killer cell activation in response to IL-12 and IL-18
Miyake, T., Satoh, T., Kato, H., Matsushita, K., Kumagai, Y., Vandenbon, A., Tani, T., Muta, T., Akira, S., & Takeuchi, O. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012977107 · Cited by 51
Murinello, S., Mullins, R. F., Lotery, A. J., Perry, V. H., & Teeling, J. L. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-11821 · Cited by 51
Marcos‐Jiménez, A., Sánchez‐Alonso, S., Alcaraz‐Serna, A., Esparcia, L., López‐Sanz, C., Sampedro-Nuñez, M. A., Mateu‐Albero, T., Sánchez‐Cerrillo, I., Martínez‐Fleta, P., Gabrie, L., et al. (2020) · European Journal of Immunology · doi:10.1002/eji.202048858 · Cited by 60
Davar, D., Zappasodi, R., Wang, H., Naik, G. S., Sato, T., Bauer, T. M., Bajor, D. L., Rixe, O., Newman, W., Qi, J., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0339 · Cited by 56
The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment
Chen, X., Cao, M., Wang, P., Chu, S., Li, M., Hou, P., Zheng, J., Li, Z., & Bai, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.968755 · Cited by 67
Sugita, T., Katayama, M., Okochi, M., Kato, R., Ichihara, T., & Honda, H. (2013) · Biochemical Engineering Journal · doi:10.1016/j.bej.2013.06.017 · Cited by 51
CD83-stimulated monocytes suppress T-cell immune responses through production of prostaglandin E2
Chen, L., Yibei, Z., Zhang, G., Gao, C., Zhong, W., & Zhang, X. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018994108 · Cited by 51
Yan, C., Zhu, M., Staiger, J., Johnson, P. F., & Gao, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.280834 · Cited by 51
“However, human Fc RIIA has an immunoreceptor tyrosine-based activationmotif in its cytosolic domain, which is not present in mouse Fc RIII and does not require -chain for functionality (1).”
BackgroundInfluentialKrupa, A., Fol, M., Rahman, M., Stokes, K. Y., Florence, J., Leskov, I. L., Khoretonenko, M. V., Matthay, M. A., Liu, K. D., Calfee, C. S., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00234.2013 · Cited by 56
FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation
Crawford, J. R., Pilling, D., & Gomer, R. H. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112033 · Cited by 50
Intracellular Tumor-Associated Antigens Represent Effective Targets for Passive Immunotherapy
Noguchi, T., Kato, T., Wang, L., Maeda, Y., Ikeda, H., Sato, E., Knuth, A. K., Gnjatic, S., Ritter, G., Sakaguchi, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3072 · Cited by 51
“The possibility that 5-FU-induced tumor destruction stimulates inflammation signals, such as Toll-like receptor signals, and these inflammation signals may change the ratio of stimulatory/inhibitory Fc receptor expression to a more stimulatory condition (8) is less likely, because our preliminary data shows that the”
BackgroundMethodInfluentialMolecular Mechanisms of Phagosome Formation
Jaumouillé, V., & Grinstein, S. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0013-2015 · Cited by 60
“For instance, IgG specifically bound to microbial surface antigens associates with phagocyte FcγRs that recognize their fragment crystallizable (Fc) region (27, 28).”
BackgroundHendriks, D., Choi, G., de Bruyn, M., Wiersma, V. R., & Bremer, E. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2016.10.002 · Cited by 67
Olaru, F., Döbel, T., Lonsdorf, A. S., Oehrl, S., Maas, M., Enk, A., Schmitz, M., Gröne, E., Gröne, H.-J., & Schäkel, K. (2018) · JCI Insight · doi:10.1172/jci.insight.96492 · Cited by 51
Morgan, H., Tseng, S.-Y., Gallais, Y., Leineweber, M., Buchmann, P., Riccardi, S., Nabhan, M., Lo, J., Gani, Z., Szely, N., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00601 · Cited by 56
“In the case of antibodies, Syk recruitment suggests the engagement of Fc receptors by native or aggregated forms (41).”
BackgroundBigay, J., Grand, R. L., Martinon, F., & Maisonnasse, P. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.932408 · Cited by 57
“Non-neutralizing, sub-neutralizing, and/or suboptimal concentrations of otherwise potent antibodies can have disproportionate Fc-mediated functions, through receptors for the Fc-region of antibodies (FcRs), which can alter immune responses (Nimmerjahn and Ravetch, 2007).”
BackgroundZhao, M. F., Wigren, M., Dunér, P., Kolbus, D., Olofsson, K. E., Björkbacka, H., Nilsson, J. Å., & Fredrikson, G. N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902654 · Cited by 51
“Alterations in the expression ratio of activating/inhibitory FcgR could impair regulated priming of Ag-specific T cells (22).”
BackgroundCD19 and CD32b Differentially Regulate Human B Cell Responsiveness
Karnell, J. L., Dimasi, N., Karnell, F. G., Fleming, R. L., Kuta, E. G., Wilson, M., Wu, H., Gao, C., Herbst, R., & Ettinger, R. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301361 · Cited by 58
Antibody variable sequences have a pronounced effect on cellular transport and plasma half-life
Grevys, A., Frick, R., Mester, S., Flem-Karlsen, K., Nilsen, J., Foss, S., Sand, K. M. K., Emrich, T., Fischer, J. A. A., Greiff, V., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103746 · Cited by 51
Zhang, H., Li, L., & Liu, L. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.06.015 · Cited by 50
Molecular mechanism of IgE-mediated FcεRI activation
Chen, M., Su, Q., & Shi, Y. (2024) · Nature · doi:10.1038/s41586-024-08229-8 · Cited by 64
“The crosslinking of other Fc receptors, such as FcαRI and FcγRI, also elicits cell activation, endocytosis and phagocytosis 49,50 .”
Amplifying antigen-induced cellular responses with proximity labelling
Li, S., Men, Y., Wang, Z., Wu, Y., Sun, H., Yin, M., Fan, X., Deng, G., Yang, Z., Yang, T., et al. (2025) · Nature · doi:10.1038/s41586-025-09518-6 · Cited by 57
“Using TCR as a model receptor, we reasoned that such covalently amplified and densely clustered PATCH, in combination with a FITC-binding BiTE, could trigger efficient tumour cell elimination by driving TCR clustering and T cell activation 1,41,42 (Fig.”
Dendritic cells revisited in human allergic rhinitis and asthma
Froidure, A., Shen, C., & Pilette, C. (2015) · Allergy · doi:10.1111/all.12770 · Cited by 58
Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies
McEnaney, P. J., Fitzgerald, K., Zhang, A. X., Douglass, E. F., Shan, W., Balog, A., Kolesnikova, M. D., & Spiegel, D. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja509513c · Cited by 52
A Humanized Mouse Identifies the Bone Marrow as a Niche with Low Therapeutic IgG Activity
Lux, A., Seeling, M., Baerenwaldt, A., Lehmann, B., Schwab, I., Repp, R., Meidenbauer, N., Mackensen, A., Hartmann, A., Heidkamp, G. F., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.02.041 · Cited by 53
“Indeed, such studies have provided valuable insights into the mechanism of IgG activity, such as the importance of cellular Fcg receptors (FcgR) for IgG activity and the role of individual FcgRs in IgG subclass activity in vivo (Beers et al., 2008; Hogarth, 2002; Nimmerjahn and Ravetch, 2008; Takai, 2002).”
BackgroundSelf-citationChronic alloantibody mediated rejection
Smith, R. N., & Colvin, R. B. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.09.002 · Cited by 50
Fc Gamma Receptor CD64 Modulates the Inhibitory Activity of Infliximab
Wojtal, K. A., Rogler, G., Scharl, M. M., Biedermann, L., Frei, P., Fried, M., Weber, A., Eloranta, J. J., Kullak-Ublick, G. A., & Vavricka, S. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043361 · Cited by 50
Dugast, A., Stamatatos, L., Tonelli, A., Suscovich, T. J., Licht, A. F., Mikell, I., Ackerman, M. E., Streeck, H., Klasse, P. J., Moore, J. P., et al. (2014) · European Journal of Immunology · doi:10.1002/eji.201344305 · Cited by 57
Kremlitzka, M., Polgar, A., Fulop, L., Kiss, E., Poor, G., & Erdei, A. (2013) · International Immunology · doi:10.1093/intimm/dxs090 · Cited by 52
How Immunoglobulin G Antibodies Kill Target Cells
Biburger, M., Lux, A., & Nimmerjahn, F. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00003-0 · Cited by 57
Self-citationHost genetics and dengue fever
de Carvalho, C. X., Cardoso, C. C., Kehdy, F. S. G., Pacheco, A. G., & Moraes, M. O. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.11.009 · Cited by 52
Structural basis for the recognition of complex-type N-glycans by Endoglycosidase S
Trastoy, B., Klontz, E. H., Orwenyo, J., Marina, A., Wang, L., Sundberg, E. J., & Guerin, M. E. (2018) · Nature Communications · doi:10.1038/s41467-018-04300-x · Cited by 54
Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE
Galeotti, C., Victor, E. S., Karnam, A., Das, M., Gilardin, L., Maddur, M. S., Wymann, S., Vonarburg, C., Chevailler, A., Dimitrov, J. D., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.10.064 · Cited by 50
Gauthier, M., Laroye, C., Bensoussan, D., Boura, C., & Decot, V. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103261 · Cited by 56
The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
Kang, S., Gao, X., Zhang, L., Yang, E., Li, Y., & Yu, L. (2021) · Current Oncology · doi:10.3390/curroncol28020105 · Cited by 51
Neonatal Fc receptor – biology and therapeutics
Bussel, J. B., Cines, D. B., & Blumberg, R. S. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2312718 · Cited by 49
FcγRIII (CD16)‐mediated ADCC by NK cells is regulated by monocytes and FcγRII (CD32)
Bhatnagar, N., Ahmad, F., Hong, H. S., Eberhard, J. M., Lu, I., Ballmaier, M., Schmidt, R. E., Jacobs, R., & Meyer‐Olson, D. (2014) · European Journal of Immunology · doi:10.1002/eji.201444515 · Cited by 57
Kinder, M., Greenplate, A. R., Strohl, W. R., Jordan, R. E., & Brezski, R. J. (2015) · mAbs · doi:10.1080/19420862.2015.1022692 · Cited by 55
Antibody – Fc receptor interactions in protection against intracellular pathogens
Joller, N., Weber, S. S., & Oxenius, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201041340 · Cited by 56
Dubaniewicz, A., Typiak, M. J., Wybieralska, M., Szadurska-Noga, M., Nowakowski, S., Staniewicz-Panasik, A., Rogoza, K., Sternau, A., Deeg, P., & Trzonkowski, P. (2012) · Human Immunology · doi:10.1016/j.humimm.2012.05.005 · Cited by 56
Repp, R., Kellner, C., Muskulus, A., Staudinger, M., Nodehi, S. M., Glorius, P., Akramienė, D., Dechant, M., Fey, G. H., van Berkel, P. H. C., et al. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.08.003 · Cited by 56
Emerging treatments for pemphigoid diseases
Ludwig, R. J., Kalies, K., Köhl, J., Zillikens, D., & Schmidt, E. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.06.003 · Cited by 49
A comparative overview of immunoglobulin genes and the generation of their diversity in tetrapods
Sun, Y., Wei, Z., Li, N., & Zhao, Y. (2012) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2012.02.008 · Cited by 49
Thomsen, K., Christophersen, L., Bjarnsholt, T., Jensen, P. Ø., Moser, C. E., & Høiby, N. (2015) · Infection and Immunity · doi:10.1128/iai.02970-14 · Cited by 53
“To examine the role of Fc receptormediated phagocytosis, human Fc receptors (Fc RI, Fc RII, and Fc RIII) were blocked by Fc RI monoclonal antibodies (MAbs; anti-CD64), Fc RII MAbs (anti-CD16), and Fc RIII MAbs (anti-CD32) (R&D Systems, Minneapolis, MN, USA).”
BackgroundLambour, J., Naranjo‐Gómez, M., Piechaczyk, M., & Pelegrín, M. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.97 · Cited by 53
Akatsu, C., Shinagawa, K., Numoto, N., Liu, Z., Ucar, A. K., Aslam, M., Phoon, S., Adachi, T., Furukawa, K., Ito, N., et al. (2016) · The Journal of Experimental Medicine · doi:10.1084/jem.20160560 · Cited by 53
“However, FcγRIIB regulates polyclonal B cells stimulated by anti-IgM and development of lupus (Nimmerjahn and Ravetch, 2008), although rheumatoid factor is typically produced in patients with rheumatoid arthritis.”
BackgroundAn unexpected player in Gaucher disease: The multiple roles of complement in disease development
Pandey, M. K., Grabowski, G. A., & Köhl, J. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.02.006 · Cited by 52
Newling, M., Sritharan, L., van der Ham, A. J., Hoepel, W., Fiechter, R. H., de Boer, L., Zaat, S. A. J., Bisoendial, R. J., Baeten, D. L. P., Everts, B., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900172 · Cited by 47
HIV and Solid Organ Transplantation: Where Are we Now
Botha, J. F., Fabian, J., Etheredge, H. R., Conradie, F., & Tiemessen, C. T. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00460-7 · Cited by 49
Exploring the pathways to chronic lymphocytic leukemia
Stevenson, F. K., Forconi, F., & Kipps, T. J. (2021) · Blood · doi:10.1182/blood.2020010029 · Cited by 58
Phagocytic Signaling: You Can Touch, but You Can't Eat
Kinchen, J. M., & Ravichandran, K. S. (2008) · Current Biology · doi:10.1016/j.cub.2008.04.058 · Cited by 49
Yang, B., Zhang, Z., Chen, X., Wang, X.-Y., Qin, S., Du, L., Yang, C., Zhu, L., Sun, W., Zhu, Y., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci153454 · Cited by 50
Semmes, E. C., Miller, I. G., Rodgers, N. S., Phan, C. T., Hurst, J. H., Walsh, K. M., Stanton, R. J., Pollara, J., & Permar, S. R. (2023) · JCI Insight · doi:10.1172/jci.insight.167768 · Cited by 48
Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune myasthenia gravis
Thiruppathi, M., Sheng, J. R., Li, L., Prabhakar, B. S., & Meriggioli, M. N. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.014 · Cited by 48
“Fc fragments have also been tested along with adjuvants for the stimulation of protective immunity or induction of tolerance against specific antigens due to their ability to activate specific FCgRs [16].”
InfluentialScanlan, C. N., Burton, D. R., & Dwek, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801192105 · Cited by 59
Hellberg, L., Samavedam, U. K. S. R. L., Holdorf, K., Hänsel, M., Recke, A., Beckmann, T., Steinhorst, K., Boehncke, W., Kirchner, T., Möckel, N., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.91 · Cited by 48
“Activation-induced phosphorylation of Akt, ERK1/2, and p38 MAPK in neutrophils is sensitive to MP treatment After cross-linking by IC, signaling pathways initiated by different FcR start with tyrosine phosphorylation of the immunoreceptor tyrosine—based activation motifs in the receptor-associated adaptor molecules (N…”
BackgroundNorton, N., Olson, R. M., Pegram, M. D., Tenner, K., Ballman, K. V., Clynes, R., Knutson, K. L., & Perez, E. A. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0059 · Cited by 49
Jang, J.-E., Hidalgo, A., & Frenette, P. S. (2012) · Circulation Research · doi:10.1161/circresaha.112.266411 · Cited by 46
Phagosomal transport depends strongly on phagosome size
Keller, S., Berghoff, K., & Kress, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-17183-7 · Cited by 52
Tumour Necrosis Factor-α Inhibition Improves Stroke Outcome in a Mouse Model of Rheumatoid Arthritis
Bonetti, N. R., Diaz-Cañestro, C., Liberale, L., Crucet, M., Akhmedov, A., Merlini, M., Reiner, M. F., Gobbato, S., Stivala, S., Kollias, G., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-38670-z · Cited by 48
Knowns and Unknowns of Assaying Antibody-Dependent Cell-Mediated Cytotoxicity Against HIV-1
Lewis, G. K., Ackerman, M. E., Scarlatti, G., Moog, C., Robert-Guroff, M., Kent, S. J., Overbaugh, J. M., Reeves, R. K., Ferrari, G., & Thyagarajan, B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01025 · Cited by 53
Duhan, V., Hamdan, T. A., Xu, H. C., Shinde, P. V., Bhat, H., Li, F., Al-Matary, Y. S., Häussinger, D., Bezgovsek, J., Friedrich, S.-K., et al. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007797 · Cited by 51
Klontz, E. H., Li, C., Kihn, K. C., Fields, J. K., Beckett, D., Snyder, G. A., Wintrode, P. L., Deredge, D. J., Wang, L., & Sundberg, E. J. (2020) · Nature Communications · doi:10.1038/s41467-020-20044-z · Cited by 54
CRISPR screen identifies genes that sensitize AML cells to double-negative T-cell therapy
Soares, F., Chen, B., Lee, J. B., Ahmed, M., Ly, D., Tin, E., Kang, H., Zeng, Y., Akhtar, N., Minden, M. D., et al. (2020) · Blood · doi:10.1182/blood.2019004108 · Cited by 53
Therapeutic Targeting of Checkpoint Receptors within the DNAM1 Axis
Alteber, Z., Kotturi, M. F., Whelan, S., Ganguly, S., Weyl, E., Pardoll, D. M., Hunter, J., & Ophir, E. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1248 · Cited by 52
“Multiple antibodies targeting TIGIT are currently in clinical development, some with FcR binding (typically human IgG1) and others with reduced binding to FcR (Table 1).”
BackgroundInfluentialTian, H., Weber, S., Thorkildson, P., Kozel, T. R., & Pirofski, L. (2009) · Infection and Immunity · doi:10.1128/iai.01075-08 · Cited by 49
“Mouse cells express three activating receptors, I, III, and IV, and one inhibitory receptor, IIB (57).”
BackgroundInfluentialFan, L., Liu, J., Hu, W., Chen, Z., Lan, J., Zhang, T., Zhang, Y., Wu, X., Zhong, Z., Zhang, D., et al. (2024) · Cell Research · doi:10.1038/s41422-024-00945-0 · Cited by 49
Comparative Efficiency of HIV-1-Infected T Cell Killing by NK Cells, Monocytes and Neutrophils
Smalls-Mantey, A., Connors, M., & Sattentau, Q. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074858 · Cited by 47
Ho, C.-H., Chien, R., Cheng, P., Liu, J.-H., Liu, C., Su, C.-S., Wu, I., Li, I.-C., Tsai, H., Wu, S., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu388 · Cited by 53
“The Fc-glycan structure is pivotal for determining the binding tropism of IgG to FcγRs and the subsequent downstream immune activities [18].”
BackgroundKim, S., Phuengkham, H., Noh, Y., Lee, H., Um, S. H., & Lim, Y. T. (2016) · Advanced Functional Materials · doi:10.1002/adfm.201603651 · Cited by 48
Kam, T.-I., Park, H., Gwon, Y., Song, S., Kim, S.-H., Moon, S. W., Jo, D.-G., & Jung, Y.-K. (2016) · eLife · doi:10.7554/elife.18691 · Cited by 49
Rajalingam, R. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00585 · Cited by 44
Patin, E. C., Geffken, A. C., Willcocks, S., Leschczyk, C., Haas, A., Nimmerjahn, F., Lang, R., Ward, T. H., & Schaible, U. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174973 · Cited by 60
Self-citationYang, Q., An, Y., Zhu, S., Zhang, R., Loke, C. M., Cipollo, J. F., & Wang, L. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00282 · Cited by 52
Bloemendaal, F. M., Koelink, P. J., van Schie, K. A., Rispens, T., Peters, C. P., Buskens, C. J., van der Bilt, J. D. W., Bemelman, W. A., Korf, H., Sabino, J., et al. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy075 · Cited by 50
Mishra, H. K., Pore, N., Michelotti, E. F., & Walcheck, B. K. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2193-1 · Cited by 52
Liu, Y., Xin, Z.-Z., Song, J., Zhu, X., Liu, Q., Zhang, D.-Z., Tang, B., Zhou, C., & Dai, L. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b01645 · Cited by 50
Happonen, L., Hauri, S., Birkedal, G. S., Karlsson, C. A. Q., de Neergaard, T., Khakzad, H., Nordenfelt, P., Wikström, M., Wisniewska, M., Björck, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10583-5 · Cited by 50
Influenza A Virus Antibodies with Antibody-Dependent Cellular Cytotoxicity Function
Gao, R., Sheng, Z., Sreenivasan, C. C., Wang, D., & Li, F. (2020) · Viruses · doi:10.3390/v12030276 · Cited by 50
Contributions of Major Cell Populations to Sjögren’s Syndrome
Witas, R., Gupta, S., & Nguyen, C. Q. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9093057 · Cited by 50
The Role of Natural Killer Cells in Humoral Rejection
Resch, T., Fabritius, C., Ebner, S., Ritschl, P. V., & Kotsch, K. (2015) · Transplantation · doi:10.1097/tp.0000000000000757 · Cited by 47
van Lent, P. L., Grevers, L. C., Schelbergen, R. F. P., Blom, A. B., Geurts, J., Sloetjes, A. W., Vogl, T., Roth, J., & van den Berg, W. B. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27654 · Cited by 47
Nechansky, A. (2009) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2009.07.013 · Cited by 47
Kaur, K., Safaie, T., Ko, M.-W., Wang, Y., & Jewett, A. (2021) · Cancers · doi:10.3390/cancers13020239 · Cited by 46
Kim, C., Galloway, J. F., Lee, K. H., & Searson, P. C. (2014) · Bioconjugate Chemistry · doi:10.1021/bc5003778 · Cited by 52
Machado, L. R., Hardwick, R. J., Bowdrey, J., Bogle, H., Knowles, T. J., Sironi, M., & Hollox, E. J. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.018 · Cited by 46
Mechanisms of IVIG Efficacy in Chronic Inflammatory Demyelinating Polyneuropathy
Tackenberg, B., Nimmerjahn, F., & Lünemann, J. D. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9398-1 · Cited by 48
“Decreased FcγRIIB expression or nonfunctional FcγRIIB variants have been shown to be associated with the development and severity of systemic lupus erythematosus in several human populations [24, 27].”
BackgroundSelf-citationEffector mechanisms of therapeutic antibodies against ErbB receptors
Peipp, M., Dechant, M., & Valerius, T. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.05.012 · Cited by 63
Characterization of anti-CD20 monoclonal antibody produced by transgenic silkworms (Bombyx mori)
Tada, M., Tatematsu, K., Ishii‐Watabe, A., Harazono, A., Takakura, D., Hashii, N., Sezutsu, H., & Kawasaki, N. (2015) · mAbs · doi:10.1080/19420862.2015.1078054 · Cited by 48
Hirako, I. C., Gallego-Marín, C., Ataide, M. A., Andrade, W. A., Gravina, H. D., Rocha, B. C., DeOliveira, R. B., Pereira, D. B., Vinetz, J. M., Diamond, B., et al. (2015) · mBio · doi:10.1128/mbio.01605-15 · Cited by 52
Engineered IgG1‐Fc – one fragment to bind them all
Laurent, E., Traxlmayr, M. W., Obinger, C., & Hasenhindl, C. (2016) · Immunological Reviews · doi:10.1111/imr.12385 · Cited by 51
Gao, Q., Mamatyusupu, D., Štambuk, J., Wang, H., Zhao, F., Yiliham, N., Wang, Y., Trbojević‐Akmačić, I., Zhang, J., Fang, H., et al. (2017) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0044 · Cited by 51
“Glycans that lack terminal galactose activate complement and make IgG pro-inflammatory, while the addition of galactose decreases the inflammatory potential of IgG (Mihai and Nimmerjahn, 2013; Nimmerjahn and Ravetch, 2008).”
Bosseboeuf, A., Allain‐Maillet, S., Mennesson, N., Tallet, A., Rossi, C., Garderet, L., Caillot, D., Moreau, P., Piver, É., Girodon, F., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01347 · Cited by 50
Mu, L., Tu, Z., Miao, L., Ruan, H., Kang, N., Hei, Y., Chen, J., Wei, W., Gong, F., Wang, B., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06744-7 · Cited by 51
Metadata
- Authors
- Nimmerjahn, F., & Ravetch, J. V.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Rockefeller University (US)
- Venue
- Nature Reviews Immunology
- Published
- 2008-01
- Volume
- 8
- Issue
- 1
- Pages
- 34-47
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2075901113
- Cited by
- 2,947
- References
- 139
- Citations by year
- 2026: 186 · 2025: 176 · 2024: 158 · 2023: 174 · 2022: 169 · 2021: 196 · 2020: 158 · 2019: 188 · 2018: 151 · 2017: 161 · 2016: 158 · 2015: 170 · 2014: 165 · 2013: 162 · 2012: 181
- FWCI
- 11.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- Fc gamma receptor, IgG, antibody subclasses, immune regulation, therapeutic antibodies, autoimmune disease, infectious diseases, cancer immunotherapy, antibody effector functions
- MeSH terms
- Animals, Humans, Immunoglobulin G, Immunity, Receptors, Fc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.